ClinicalTrials.gg
CompletedNCT07212608Updated Nov 13, 2026Results posted

Personalized Post-Stroke Gait Rehabilitation Interventions

An interventional study of Soft robotic exosuit and Neuroprosthesis in Stroke, sponsored by Boston University Charles River Campus. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years 6 months after the study started (first participant enrolled Sep 2022, registered Mar 2025).
Updated Nov 13, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,995 studies in Stroke with a site in United States — 392 open to participants now, 490 under way, 17 of them phase 3. Stroke · United States.

Enrollment
1,077th of 1,621
22 · median 40
Started
2022
with 101 others
No phase
1,124 of 1,995
270 open now
Registered
1,827th of 1,995
by date

Among the 1,995 studies in Stroke with a site in United States, this one is the 1,077th largest by enrollment of the 1,621 interventional ones that give a count, is one of 102 that started in 2022, is one of 1,124 with no phase, and was the 1,827th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

392 of the 1,995 studies in Stroke with a site in United States are open now. Recruiting first, the newest first:

387 more — sign in →

All 392 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,995 studies in Stroke with a site in United States, or all of them as a file.
02

Study summary

The objective of this study is to understand whether certain post-stroke patient subsets, identified from clinical, biomechanical, and neuromuscular characteristics, preferentially respond to different walking rehabilitation interventions that augment paretic limb propulsion (e.g., soft robotic exosuits or electrical stimulation neuroprostheses). The results of this work could improve post-stroke gait recovery outcomes by informing clinical decision-making to better match patients with rehabilitation devices tailored to their specific gait characteristics.

Read the detailed description

Stroke is a leading cause of long-term disability that results in slow, asymmetrical, and inefficient walking. Personalized treatments matching patients to the treatments with which they are most likely to respond are not typical but are necessary to maximize recovery.

Post-stroke hemiparesis is commonly associated with reduced paretic limb propulsion that leads to slower, less efficient walking patterns. Our team has developed and tested two rehabilitation technologies targeting paretic propulsion: i) a soft robotic exosuit that uses cables to mechanically assist ankle dorsiflexion and plantarflexion during walking; ii) a neuroprosthesis that uses functional electrical stimulation (FES) to activate the dorsiflexor and plantarflexor muscles during walking. Both technologies aim to safely improve walking speed and paretic propulsion. The objective of this study is to evaluate if certain post-stroke patient subsets, identified from baseline clinical, biomechanical, and neuromuscular characteristics, preferentially respond to propulsion rehabilitation using soft robotic exosuits or electrical stimulation neuroprostheses.

Twenty participants with chronic (>6 months) stroke will complete one baseline gait evaluation in the laboratory and two gait training sessions: i) an exosuit day and ii) a neuroprosthesis day. Each visit will include walking with/without the respective technology.

The primary aim of this study is to identify predictors of a therapeutic response (i.e., improvement in walking speed) to determine whether certain patient subsets preferentially respond to the exosuit or the neuroprosthesis. The investigators will evaluate baseline clinical, biomechanical, and neuromuscular abilities as potential predictors of a response. The investigators hypothesize that a subset of individuals will respond preferentially to each intervention and that baseline measures of gait function will predict responders to each intervention.

A secondary aim of this study is to determine the rehabilitation mechanism underlying improved walking speed after walking with the propulsion exosuit and the neuroprosthesis. Improvements in walking speed can be achieved through recovery (e.g., increased propulsion symmetry) or compensation (e.g., increased nonparetic propulsion). We will independently evaluate the underlying biomechanical changes contributing to improvements in speed and metabolic cost. We hypothesize that both the exosuit and neuroprosthesis will promote improved speed via recovery of paretic propulsion.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Exosuit
  • Neuroprosthesis
  • Soft Robotics
  • Wearable Robots
  • Gait Rehabilitation
  • Propulsion
  • Functional Electrical Stimulation (FES)
  • Stroke
  • Neuromuscular Control
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of a stroke event occurring at least 6 months ago
  • Observable gait deficits
  • Independent ambulation for at least 30 meters (using an assistive device as needed but without a rigid brace or ankle foot orthosis)
  • Passive ankle dorsiflexion range of motion to neutral with the knee extended
  • Ability to follow a 3-step command
  • Resting heart rate between 40-100 bpm
  • Resting blood pressure between 90/60 and 170/90 mmHg
  • NIH Stroke Scale Question 1b score > 1 and Question 1c score > 0
  • HIPAA authorization to allow communication with healthcare provider
  • Medical clearance by a physician

Exclusion criteria

Exclusion Criteria:

  • Severe aphasia or inability to communicate with investigators
  • Neglect or hemianopia
  • Score of >1 on question 1b and >0 on question 1c on the NIH Stroke Scale
  • Serious comorbidities that may interfere with ability to participate in the research (e.g., musculoskeletal, cardiovascular, pulmonary)
  • Pacemakers or similar electrical implants that could be affected by the FES
  • Pressure ulcers or skin wounds located near human-device interface sites
  • More than 2 unexplained falls in the previous month
  • Actively receiving physical therapy for walking
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Neuroprosthesis Gait Training First, then Exosuit Gait Training

    Participants completed a total of two gait training visits with a gait rehabilitation device: the first visit using a neuroprosthesis, and the second visit using a soft robotic exosuit. Gait training for each visit consists of 30 minutes of goal-directed overground walking practice at a moderately fast speed with a gait rehabilitation device that provides periods of active assistance and periods of no assistance targeting the enhancement of paretic limb gait propulsion. Shorter overground and treadmill evaluations without the gait rehabilitation device will be completed immediately before and after the gait training session to assess the short-term retention of biomechanical outcomes.

    Device: Soft robotic exosuit · Device: Neuroprosthesis

  • Experimental
    Exosuit Gait Training First, then Neuroprosthesis Gait Training

    Participants complete a total of two gait training visits with a gait rehabilitation device: the first visit using a soft robotic exosuit, and the second visit using a neuroprosthesis. Gait training for each visit consists of 30 minutes of goal-directed overground walking practice at a moderately fast speed with a gait rehabilitation device that provides periods of active assistance and periods of no assistance targeting the enhancement of paretic limb gait propulsion. Shorter overground and treadmill evaluations without the gait rehabilitation device will be completed immediately before and after the gait training session to assess the short-term retention of biomechanical outcomes.

    Device: Soft robotic exosuit · Device: Neuroprosthesis

Interventions

  • DeviceSoft robotic exosuit

    A soft robotic exosuit is a textile-based system worn on the waist and paretic lower limb that provides assistive torques via cables connecting the front and back of the ankle to anchor points on the shank. The exosuit provides dorsiflexion assistance during swing phase for foot clearance and plantarflexion assistance during stance phase for propulsion delivered synchronously based on integrated sensors detecting the wearer's gait pattern.

  • DeviceNeuroprosthesis

    A neuroprosthesis is a textile-based, surface electrical stimulation system worn on the waist and paretic lower limb that delivers stimulation assistance via electroconductive pads placed on the skin over the target muscles. The neuroprosthesis provides coordinated dorsiflexor stimulation during swing phase for foot clearance and plantarflexor stimulation during stance phase for propulsion, delivered synchronously based on integrated sensors detecting the wearer's gait pattern.

06

What researchers measure

Primary outcomes

  1. Fast Walking Speed (Overground)

    Walking speed measured without assistance from a device during walking at a self-selected fast pace using the average of two walks around a 26.6-meter track.

    Time frame: Periprocedural (Before); Periprocedural (After)

  2. Paretic Propulsion (Treadmill)

    Paretic propulsion measured without assistance from a device during walking on the treadmill at a speed determined by the average walking speed during the 6-Minute Walk Test completed on the Baseline Evaluation. Paretic propulsion was calculated as the peak anterior-posterior ground reaction force of the paretic limb.

    Time frame: Periprocedural (Before); Periprocedural (After)

  3. Energy Cost of Walking (Treadmill)

    Energy cost measured without assistance from a device during walking on the treadmill at a speed determined by the average walking speed during the 6-Minute Walk Test completed on the Baseline Evaluation. Energy cost is measured using indirect calorimetry on a breath-by-breath basis and is calculated as the net oxygen consumption (mL/min) during walking with respect to standing rest and normalized by bodyweight (kg) and speed (m/s). Equation: energy cost (mL/kg/m) = \[Oxygen\_walking(mL/min) - Oxygen\_stand(mL/min)\] / Bodyweight(kg) / Speed(m/s) \* 60(s/min).

    Time frame: Periprocedural (Before); Periprocedural (After)

07

Results

Posted Nov 13, 2026

Participant flow

First Intervention (1 Training Day)
Participant flow — First Intervention (1 Training Day)
MilestoneNeuroprosthesis Training Followed by Exosuit TrainingExosuit Training Followed by Neuroprosthesis Training
Started1012
Received training1012
Completed1012
Not completed00
Time Between Training (At Least 2 Days)
Participant flow — Time Between Training (At Least 2 Days)
MilestoneNeuroprosthesis Training Followed by Exosuit TrainingExosuit Training Followed by Neuroprosthesis Training
Started1012
Completed1012
Not completed00
Second Intervention (1 Training Day)
Participant flow — Second Intervention (1 Training Day)
MilestoneNeuroprosthesis Training Followed by Exosuit TrainingExosuit Training Followed by Neuroprosthesis Training
Started1012
Received training1012
Completed1012
Not completed00

Outcome measures

PrimaryFast Walking Speed (Overground)

Walking speed measured without assistance from a device during walking at a self-selected fast pace using the average of two walks around a 26.6-meter track.

Time frame:
Periprocedural (Before); Periprocedural (After)
Reported as:
Mean · meters per second (m/s)
Fast Walking Speed (Overground)
meters per second (m/s)Neuroprosthesis TrainingExosuit Training
Before1.09 ± 0.071.08 ± 0.07
After1.17 ± 0.071.17 ± 0.07
Statistical analysis
  • Neuroprosthesis Training · t-test, 2 sided · p = <0.001 (Effect Size (Cohen's D) = 0.24) · Mean difference (final values): 0.08Difference = After - Before
  • Exosuit Training · t-test, 2 sided · p = <0.001 (Effect Size (Cohen's D) = 0.27) · Mean difference (final values): 0.09Difference = After - Before
  • Neuroprosthesis Training vs Exosuit Training · t-test, 2 sided · p = 0.725 (Effect Size (Cohen's D) = 0.11) · Mean difference (net): -0.01Difference = Change (Neuroprosthesis) - Change (Exosuit)
PrimaryParetic Propulsion (Treadmill)

Paretic propulsion measured without assistance from a device during walking on the treadmill at a speed determined by the average walking speed during the 6-Minute Walk Test completed on the Baseline Evaluation. Paretic propulsion was calculated as the peak anterior-posterior ground reaction force of the paretic limb.

Time frame:
Periprocedural (Before); Periprocedural (After)
Reported as:
Mean · percent bodyweight (%bw)
Paretic Propulsion (Treadmill)
percent bodyweight (%bw)Neuroprosthesis TrainingExosuit Training
Before10.10 ± 1.159.97 ± 1.11
After10.27 ± 1.1610.13 ± 1.08
Statistical analysis
  • Neuroprosthesis Training · t-test, 2 sided · p = 0.460 (Effect Size (Cohen's D) = 0.03) · Mean difference (final values): 0.18Difference = After - Before
  • Exosuit Training · t-test, 2 sided · p = 0.487 (Effect Size (Cohen's D) = 0.03) · Mean difference (final values): 0.16Difference = After - Before
  • Neuroprosthesis Training vs Exosuit Training · t-test, 2 sided · p = 0.944 (Effect Size (Cohen's D) = -0.02) · Mean difference (net): 0.02Difference = Change (Neuroprosthesis) - Change (Exosuit)
PrimaryEnergy Cost of Walking (Treadmill)

Energy cost measured without assistance from a device during walking on the treadmill at a speed determined by the average walking speed during the 6-Minute Walk Test completed on the Baseline Evaluation. Energy cost is measured using indirect calorimetry on a breath-by-breath basis and is calculated as the net oxygen consumption (mL/min) during walking with respect to standing rest and normalized by bodyweight (kg) and speed (m/s). Equation: energy cost (mL/kg/m) = \[Oxygen\_walking(mL/min) - Oxygen\_stand(mL/min)\] / Bodyweight(kg) / Speed(m/s) \* 60(s/min).

Time frame:
Periprocedural (Before); Periprocedural (After)
Reported as:
Mean · mL O2/kg/m
Energy Cost of Walking (Treadmill)
mL O2/kg/mNeuroprosthesis TrainingExosuit Training
Before0.209 ± 0.0100.209 ± 0.013
After0.202 ± 0.0080.207 ± 0.015
Statistical analysis
  • Neuroprosthesis Training · t-test, 2 sided · p = 0.207 (Effect Size (Cohen's D) = -0.18) · Mean difference (final values): -0.01Difference = After - Before
  • Exosuit Training · t-test, 2 sided · p = 0.781 (Effect Size (Cohen's D) = -0.03) · Mean difference (final values): -0.00Difference = After - Before
  • Neuroprosthesis Training vs Exosuit Training · t-test, 2 sided · p = 0.536 (Effect Size (Cohen's D) = 0.18) · Mean difference (net): -0.01Difference = Change (Neuroprosthesis) - Change (Exosuit)

Adverse events

Collected over Duration of study from Baseline Evaluation to final gait training day (range: 1.14 to 6.14 weeks, average: 2.73 weeks).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Neuroprosthesis Training0/22 (0%)0/22 (0%)0/22 (0%)
Exosuit Training0/22 (0%)0/22 (0%)0/22 (0%)

Baseline characteristics

A total of 22 participants enrolled in the study, 10 of whom completed the neuroprosthesis training visit followed byr the exosuit training visit and 12 of whom completed the exosuit training visit followed by the neuroprosthesis training visit.

Age, Continuous
Age, Continuous(years)Neuroprosthesis Training First Followed by Exosuit TrainingExosuit Training First Followed by NeuroprosthesisTotal
Mean55.4 ± 12.559.6 ± 10.057.7 ± 11.1
Sex: Female, Male
Sex: Female, Male(Participants)Neuroprosthesis Training First Followed by Exosuit TrainingExosuit Training First Followed by NeuroprosthesisTotal
Female123
Male91019
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Neuroprosthesis Training First Followed by Exosuit TrainingExosuit Training First Followed by NeuroprosthesisTotal
Hispanic or Latino033
Not Hispanic or Latino10717
Unknown or Not Reported022
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Neuroprosthesis Training First Followed by Exosuit TrainingExosuit Training First Followed by NeuroprosthesisTotal
American Indian or Alaska Native000
Asian101
Native Hawaiian or Other Pacific Islander000
Black or African American022
White9918
More than one race000
Unknown or Not Reported011
Paretic Side
Paretic Side(Participants)Neuroprosthesis Training First Followed by Exosuit TrainingExosuit Training First Followed by NeuroprosthesisTotal
Left7815
Right347
Chronicity
Chronicity(years)Neuroprosthesis Training First Followed by Exosuit TrainingExosuit Training First Followed by NeuroprosthesisTotal
Mean7.4 ± 4.75.2 ± 3.66.2 ± 4.2
08

Study locations

1 site
  • Boston University Neuromotor Recovery Laboratory
    Boston, Massachusetts 02215, United States
09

References and documents

Publications

  • Awad LN, Bae J, O'Donnell K, et al. Soft exosuits increase walking speed and distance after stroke. In: International Symposium on Wearable Robotics and Rehabilitation (WeRob). Houston, TX: IEEE; 2; 2017.
  • Awad LN, Bae J, Kudzia P, Long A, Hendron K, Holt KG, O'Donnell K, Ellis TD, Walsh CJ. Reducing Circumduction and Hip Hiking During Hemiparetic Walking Through Targeted Assistance of the Paretic Limb Using a Soft Robotic Exosuit. Am J Phys Med Rehabil. 2017 Oct;96(10 Suppl 1):S157-S164. doi: 10.1097/PHM.0000000000000800. PubMed 28777105 ↗
  • Awad LN, Bae J, O'Donnell K, De Rossi SMM, Hendron K, Sloot LH, Kudzia P, Allen S, Holt KG, Ellis TD, Walsh CJ. A soft robotic exosuit improves walking in patients after stroke. Sci Transl Med. 2017 Jul 26;9(400):eaai9084. doi: 10.1126/scitranslmed.aai9084. PubMed 28747517 ↗
  • Bae J, Awad LN, Long A, O'Donnell K, Hendron K, Holt KG, Ellis TD, Walsh CJ. Biomechanical mechanisms underlying exosuit-induced improvements in walking economy after stroke. J Exp Biol. 2018 Mar 7;221(Pt 5):jeb168815. doi: 10.1242/jeb.168815. PubMed 29361587 ↗
  • Ardestani MM, Kinnaird CR, Henderson CE, Hornby TG. Compensation or Recovery? Altered Kinetics and Neuromuscular Synergies Following High-Intensity Stepping Training Poststroke. Neurorehabil Neural Repair. 2019 Jan;33(1):47-58. doi: 10.1177/1545968318817825. Epub 2018 Dec 29. PubMed 30595090 ↗
  • Paci M. Physiotherapy based on the Bobath concept for adults with post-stroke hemiplegia: a review of effectiveness studies. J Rehabil Med. 2003 Jan;35(1):2-7. doi: 10.1080/16501970306106. PubMed 12610841 ↗
  • Roelker SA, Bowden MG, Kautz SA, Neptune RR. Paretic propulsion as a measure of walking performance and functional motor recovery post-stroke: A review. Gait Posture. 2019 Feb;68:6-14. doi: 10.1016/j.gaitpost.2018.10.027. Epub 2018 Oct 25. PubMed 30408710 ↗
  • Bowden MG, Balasubramanian CK, Neptune RR, Kautz SA. Anterior-posterior ground reaction forces as a measure of paretic leg contribution in hemiparetic walking. Stroke. 2006 Mar;37(3):872-6. doi: 10.1161/01.STR.0000204063.75779.8d. Epub 2006 Feb 2. PubMed 16456121 ↗
  • Bae J, Siviy C, Rouleau M, et al. A lightweight and efficient portable soft exosuit for paretic ankle assistance in walking after stroke. Proc - IEEE Int Conf Robot Autom. 2018:2820-2827. doi:10.1109/ICRA.2018.8461046
  • Awad LN, Kudzia P, Revi DA, Ellis TD, Walsh CJ. Walking faster and farther with a soft robotic exosuit: Implications for post-stroke gait assistance and rehabilitation. IEEE Open J Eng Med Biol. 2020;1:108-115. doi: 10.1109/ojemb.2020.2984429. Epub 2020 Apr 2. PubMed 33748765 ↗
  • Porciuncula F, Arumukhom Revi D, Baker TC, et al. Speed-Based Gait Training with Soft Robotic Exosuits Improves Walking after Stroke: A Crossover Pilot Study. In: American Physical Therapy Association Combined Sections Meeting.; 2021.
  • Kesar TM, Reisman DS, Higginson JS, Awad LN, Binder-Macleod SA. Changes in Post-Stroke Gait Biomechanics Induced by One Session of Gait Training. Phys Med Rehabil Int. 2015;2(10):1072. Epub 2015 Dec 28. PubMed 27819067 ↗
  • Awad LN, Reisman DS, Pohlig RT, Binder-Macleod SA. Identifying candidates for targeted gait rehabilitation after stroke: better prediction through biomechanics-informed characterization. J Neuroeng Rehabil. 2016 Sep 23;13(1):84. doi: 10.1186/s12984-016-0188-8. PubMed 27663199 ↗
  • Reisman D, Kesar T, Perumal R, Roos M, Rudolph K, Higginson J, Helm E, Binder-Macleod S. Time course of functional and biomechanical improvements during a gait training intervention in persons with chronic stroke. J Neurol Phys Ther. 2013 Dec;37(4):159-65. doi: 10.1097/NPT.0000000000000020. PubMed 24189337 ↗
  • Awad LN, Kesar TM, Reisman D, Binder-Macleod SA. Effects of repeated treadmill testing and electrical stimulation on post-stroke gait kinematics. Gait Posture. 2013 Jan;37(1):67-71. doi: 10.1016/j.gaitpost.2012.06.001. Epub 2012 Jul 15. PubMed 22796242 ↗
  • Sabut SK, Lenka PK, Kumar R, Mahadevappa M. Effect of functional electrical stimulation on the effort and walking speed, surface electromyography activity, and metabolic responses in stroke subjects. J Electromyogr Kinesiol. 2010 Dec;20(6):1170-7. doi: 10.1016/j.jelekin.2010.07.003. Epub 2010 Aug 6. PubMed 20692180 ↗
  • Koelewijn AD, Audu M, Del-Ama AJ, Colucci A, Font-Llagunes JM, Gogeascoechea A, Hnat SK, Makowski N, Moreno JC, Nandor M, Quinn R, Reichenbach M, Reyes RD, Sartori M, Soekadar S, Triolo RJ, Vermehren M, Wenger C, Yavuz US, Fey D, Beckerle P. Adaptation Strategies for Personalized Gait Neuroprosthetics. Front Neurorobot. 2021 Dec 16;15:750519. doi: 10.3389/fnbot.2021.750519. eCollection 2021. PubMed 34975445 ↗
  • Bajd T, Munih M. VI.2. Basic functional electrical stimulation (FES) of extremites - an engineer's view. Stud Health Technol Inform. 2010;152:343-52. PubMed 20407203 ↗
  • Embrey DG, Holtz SL, Alon G, Brandsma BA, McCoy SW. Functional electrical stimulation to dorsiflexors and plantar flexors during gait to improve walking in adults with chronic hemiplegia. Arch Phys Med Rehabil. 2010 May;91(5):687-96. doi: 10.1016/j.apmr.2009.12.024. PubMed 20434604 ↗
  • Kesar TM, Perumal R, Reisman DS, Jancosko A, Rudolph KS, Higginson JS, Binder-Macleod SA. Functional electrical stimulation of ankle plantarflexor and dorsiflexor muscles: effects on poststroke gait. Stroke. 2009 Dec;40(12):3821-7. doi: 10.1161/STROKEAHA.109.560375. Epub 2009 Oct 15. PubMed 19834018 ↗
  • Palmer JA, Hsiao H, Wright T, Binder-Macleod SA. Single Session of Functional Electrical Stimulation-Assisted Walking Produces Corticomotor Symmetry Changes Related to Changes in Poststroke Walking Mechanics. Phys Ther. 2017 May 1;97(5):550-560. doi: 10.1093/ptj/pzx008. PubMed 28339828 ↗
  • Awad LN, Reisman DS, Pohlig RT, Binder-Macleod SA. Reducing The Cost of Transport and Increasing Walking Distance After Stroke: A Randomized Controlled Trial on Fast Locomotor Training Combined With Functional Electrical Stimulation. Neurorehabil Neural Repair. 2016 Aug;30(7):661-70. doi: 10.1177/1545968315619696. Epub 2015 Nov 30. PubMed 26621366 ↗
  • Reisman DS, Binder-MacLeod S, Farquhar WB. Changes in metabolic cost of transport following locomotor training poststroke. Top Stroke Rehabil. 2013 Mar-Apr;20(2):161-70. doi: 10.1310/tsr2002-161. PubMed 23611857 ↗
  • Clark DJ, Ting LH, Zajac FE, Neptune RR, Kautz SA. Merging of healthy motor modules predicts reduced locomotor performance and muscle coordination complexity post-stroke. J Neurophysiol. 2010 Feb;103(2):844-57. doi: 10.1152/jn.00825.2009. Epub 2009 Dec 9. PubMed 20007501 ↗
  • Steele KM, Rozumalski A, Schwartz MH. Muscle synergies and complexity of neuromuscular control during gait in cerebral palsy. Dev Med Child Neurol. 2015 Dec;57(12):1176-82. doi: 10.1111/dmcn.12826. Epub 2015 Jun 17. PubMed 26084733 ↗
  • Collimore AN, Aiello AJ, Pohlig RT, Awad LN. The Dynamic Motor Control Index as a Marker of Age-Related Neuromuscular Impairment. Front Aging Neurosci. 2021 Jul 22;13:678525. doi: 10.3389/fnagi.2021.678525. eCollection 2021. PubMed 34366824 ↗
  • Collimore AN, Pohlig RT, Awad LN. Minimal viable muscle set for identifying impairments in the neuromuscular control of walking using the dynamic motor control index. In: North American Congress on Biomechanics. Ottawa, CA. 2022.
  • Collimore AN, Aiello AJM, Pohlig RT, Awad LN. The dynamic motor control index is a better marker of age-related neuromotor impairments than the number of muscle synergies: Toward early detection of walking deficits. Neural Control of Movement Annual Meeting. Virtual. 2021.
  • Choe DK, Aiello AJ, Spangler JE, Walsh CJ, Awad LN. A Propulsion Neuroprosthesis Improves Overground Walking in Community-Dwelling Individuals After Stroke. IEEE Open J Eng Med Biol. 2024 Jul 4;5:563-572. doi: 10.1109/OJEMB.2024.3416028. eCollection 2024. PubMed 39157060 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2022 to primary completion in Apr 2025, 31 months.

Results were first posted in Nov 2026, 1 year 6 months after primary completion.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 31 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 28, 2025
First posted
Oct 8, 2025
StartActual
Sep 13, 2022
Primary completionActual
Apr 24, 2025
CompletionActual
Apr 24, 2025
Results first posted
Nov 13, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 13, 2026
Interventions
Changed Propulsion neuroprosthesis→Neuroprosthesis. Arms added: Neuroprosthesis Gait Training First, then Exosuit Gait Training·Exosuit Gait Training First, then Neuroprosthesis Gait Training; arms removed: Exosuit Training·Neuroprosthesis Training
Nov 13, 2026
Primary outcomes
2 edited, 1 added, 6 removed
What changed in the outcomes
  • EditedUnassisted Overground ComfortableFast Walking Speed (Exosuit DayOverground)Time frame: Periprocedural (Before); Periprocedural (After)
  • EditedUnassisted Paretic Propulsion on (Treadmill (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • AddedEnergy Cost of Walking (Treadmill)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Overground Fast Walking Speed (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Energy Efficiency on Treadmill (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Overground Comfortable Walking Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Overground Fast Walking Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Paretic Propulsion on Treadmill (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Energy Efficiency on Treadmill (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
Nov 13, 2026
Documents
Secondary outcomes
14 removed
What changed in the outcomes
  • RemovedUnassisted Overground Paretic Propulsion at Comfortable Speed (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Overground Paretic Trailing Limb Angle at Comfortable Speed (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Overground Paretic Propulsion at Fast Speed (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Overground Paretic Trailing Limb Angle at Fast Speed (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Paretic Trailing Limb Angle on Treadmill (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Overground Paretic Propulsion at Comfortable Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Overground Paretic Trailing Limb Angle at Comfortable Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Overground Paretic Propulsion at Fast Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Overground Paretic Trailing Limb Angle at Fast Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • RemovedUnassisted Paretic Trailing Limb Angle on Treadmill (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
  • Removedother outcomeStroke ChronicityTime frame: Baseline (Day 1)
  • Removedother outcomeSix-Minute Walk Test DistanceTime frame: Baseline (Day 1)
  • Removedother outcomeFugl-Meyer Assessment of Motor Recovery After StrokeTime frame: Baseline (Day 1)
  • Removedother outcomePlantarflexor Central DriveTime frame: Baseline (Day 1)
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Results posted
    Primary outcomes 2 edited, 1 added, 6 removed
    What changed in the outcomes
    • EditedUnassisted Overground ComfortableFast Walking Speed (Exosuit DayOverground)Time frame: Periprocedural (Before); Periprocedural (After)
    • EditedUnassisted Paretic Propulsion on (Treadmill (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • AddedEnergy Cost of Walking (Treadmill)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Overground Fast Walking Speed (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Energy Efficiency on Treadmill (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Overground Comfortable Walking Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Overground Fast Walking Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Paretic Propulsion on Treadmill (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Energy Efficiency on Treadmill (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
    Secondary outcomes 14 removed
    What changed in the outcomes
    • RemovedUnassisted Overground Paretic Propulsion at Comfortable Speed (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Overground Paretic Trailing Limb Angle at Comfortable Speed (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Overground Paretic Propulsion at Fast Speed (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Overground Paretic Trailing Limb Angle at Fast Speed (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Paretic Trailing Limb Angle on Treadmill (Exosuit Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Overground Paretic Propulsion at Comfortable Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Overground Paretic Trailing Limb Angle at Comfortable Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Overground Paretic Propulsion at Fast Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Overground Paretic Trailing Limb Angle at Fast Speed (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • RemovedUnassisted Paretic Trailing Limb Angle on Treadmill (Neuroprosthesis Day)Time frame: Periprocedural (Before); Periprocedural (After)
    • Removedother outcomeStroke ChronicityTime frame: Baseline (Day 1)
    • Removedother outcomeSix-Minute Walk Test DistanceTime frame: Baseline (Day 1)
    • Removedother outcomeFugl-Meyer Assessment of Motor Recovery After StrokeTime frame: Baseline (Day 1)
    • Removedother outcomePlantarflexor Central DriveTime frame: Baseline (Day 1)
    Interventions Changed Propulsion neuroprosthesis→Neuroprosthesis. Arms added: Neuroprosthesis Gait Training First, then Exosuit Gait Training·Exosuit Gait Training First, then Neuroprosthesis Gait Training; arms removed: Exosuit Training·Neuroprosthesis Training
    + 4 other changes: index terms, verification date, description and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07212608
Collaborators
Harvard University, American Heart Association, National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Responsible party
Lou Awad, PT, DPT, PhD (Assistant Professor, Boston University Charles River Campus) — Principal investigator
First posted
Oct 8, 2025
Start date
Sep 13, 2022
Primary completion
Apr 24, 2025
Completion
Apr 24, 2025
Results posted
Nov 13, 2026
Last update
Nov 13, 2026

Study contacts

Louis N Awad, PT, PhD
principal investigator · Boston University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion